Contact
Please use this form to send email to PR contact of this press release:
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age
TO:
Please use this form to send email to PR contact of this press release:
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age
TO: